- Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients
-
Karatas E, Aksoy L, Ozaslan E
- KMID: 2517460
- Infect Chemother.
- 2021 Jun;53(2):300-307.
- doi: 10.3947/ic.2020.0149
Background: The antiviral agent favipiravir is an RNA-dependent RNA polymerase (RdRp) inhibitor. Materials and Methods: We examined patients with a clinical, laboratory, and radiological diagnosis of severe coronavirus disease 2019 (COVID-19)... -
- CITED
-
- Close
- SHARE
-
- Close
